Keyword search
Tag search

Masao Torii

President, Novartis Holding Japan K.K.
Masao (Mark) Torii is the President of Novartis Holding Japan K.K. and has held the position since July 1, 2016. He started his career in Nippon Roche as assistant to the president and subsequently headed the diagnostic and pharmaceutical businesses. Following his 21 years in Roche in Japan, the US, and the Switzerland, he assumed the position of president of Japanese affiliates of Rhone-Poulenc Rorer, Schering-Plough and Boehringer-Ingelheim, before finally joining Novartis in 2016. He is a graduate of Loyola College, Maryland, USA (BA) and Sophia University (MBA) and completed Advanced Management Program at Harvard Business School, USA. He is currently an Executive Committee member of Swiss Chamber of Commerce and Industry in Japan.
Global Japan
NOV 22, 2017

Novartis Japan President: Using Japanese Values to Thrive in Global Business

Novartis Holding Japan President Masao Torii shares how he utilizes Japanese values to lead his companies and earn trust from the global head offices.

Global Japan
SEP 28, 2017

Do You Have What It Takes? Success in the Global Workplace

In an age of turmoil, what kind of qualities are needed to succeed in the global workplace? We asked Masao…

Global Japan
OCT 29, 2012

Competing in the Global Pharmaceutical Market 3/3

Mr. Masao Torii, President and Representative Director of Boehringer Ingelheim Japan, Inc. discusses current trends in the Global Pharmaceutical Market. Mr. Torii describes how Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, uses its uniqueness and strengths to succeed globally. He also describes his company’s role in the Japanese pharmaceutical market, including how the corporate values of Boehringer Ingelheim Japan help cultivate global leaders within the company. This seminar provides guidance and insight for people interested in strategies to compete globally as well as how to develop your own skills to become a global leader.

Global Japan
OCT 26, 2012

Competing in the Global Pharmaceutical Market 2/3

Mr. Masao Torii, President and Representative Director of Boehringer Ingelheim Japan, Inc. discusses current trends in the Global Pharmaceutical Market. Mr. Torii describes how Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, uses its uniqueness and strengths to succeed globally. He also describes his company’s role in the Japanese pharmaceutical market, including how the corporate values of Boehringer Ingelheim Japan help cultivate global leaders within the company. This seminar provides guidance and insight for people interested in strategies to compete globally as well as how to develop your own skills to become a global leader.

Global Japan
OCT 25, 2012

Competing in the Global Pharmaceutical Market 1/3

Mr. Masao Torii, President and Representative Director of Boehringer Ingelheim Japan, Inc. discusses current trends in the Global Pharmaceutical Market. Mr. Torii describes how Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, uses its uniqueness and strengths to succeed globally. He also describes his company’s role in the Japanese pharmaceutical market, including how the corporate values of Boehringer Ingelheim Japan help cultivate global leaders within the company. This seminar provides guidance and insight for people interested in strategies to compete globally as well as how to develop your own skills to become a global leader.